ACM

ADAR1 Capital Management Portfolio holdings

AUM $616M
1-Year Est. Return 26.77%
This Quarter Est. Return
1 Year Est. Return
+26.77%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$616M
AUM Growth
+$96.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
239
New
Increased
Reduced
Closed

Top Buys

1 +$52.1M
2 +$20.5M
3 +$14M
4
CTMX icon
CytomX Therapeutics
CTMX
+$6.89M
5
ABVX
Abivax
ABVX
+$6.59M

Top Sells

1 +$17.4M
2 +$8.63M
3 +$6.94M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.34M
5
AVR
Anteris Technologies
AVR
+$4.35M

Sector Composition

1 Healthcare 83.61%
2 Financials 2.95%
3 Consumer Discretionary 0%
4 Industrials 0%
5 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KROS icon
1
Keros Therapeutics
KROS
$421M
$71.9M 11.03%
5,389,264
+3,902,803
PTGX icon
2
Protagonist Therapeutics
PTGX
$4.82B
$52.4M 8.04%
948,069
+8,400
BOXX icon
3
Alpha Architect 1-3 Month Box ETF
BOXX
$8.11B
$38M 5.83%
337,125
ZLAB icon
4
Zai Lab
ZLAB
$3.15B
$29.7M 4.56%
850,437
-90,421
ABVX
5
Abivax
ABVX
$7.22B
$23.5M 3.6%
3,071,340
+861,321
ROIV icon
6
Roivant Sciences
ROIV
$11.8B
$21.9M 3.35%
1,940,797
-1,542,607
PRTA icon
7
Prothena Corp
PRTA
$534M
$20.5M 3.14%
+3,375,009
CYTK icon
8
Cytokinetics
CYTK
$6.99B
$19.2M 2.95%
582,147
+191,418
SPY icon
9
SPDR S&P 500 ETF Trust
SPY
$660B
$14M 2.15%
+22,684
CGON icon
10
CG Oncology
CGON
$3.16B
$13.6M 2.09%
523,216
+222,082
BIL icon
11
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$42B
$12.4M 1.91%
135,585
BBIO icon
12
BridgeBio Pharma
BBIO
$10.5B
$11.2M 1.72%
259,659
-79,976
IKT icon
13
Inhibikase Therapeutics
IKT
$117M
$9.99M 1.53%
5,122,105
SEPN
14
Septerna Inc
SEPN
$984M
$8.96M 1.37%
847,227
+126,379
ABUS icon
15
Arbutus Biopharma
ABUS
$845M
$8.73M 1.34%
2,825,773
+946,659
ETNB icon
16
89bio
ETNB
$2.19B
$8.6M 1.32%
875,983
+71,763
IMVT icon
17
Immunovant
IMVT
$3.05B
$8.56M 1.31%
535,066
-433,800
SVRA icon
18
Savara
SVRA
$624M
$8.21M 1.26%
3,600,670
+2,240,379
XENE icon
19
Xenon Pharmaceuticals
XENE
$3.21B
$8.12M 1.25%
259,503
+131,955
BIOA
20
BioAge Labs
BIOA
$186M
$8M 1.23%
1,937,123
+966,023
PCSC
21
Perceptive Capital Solutions
PCSC
$118M
$7.96M 1.22%
750,000
AMLX icon
22
Amylyx Pharmaceuticals
AMLX
$1.59B
$7.72M 1.18%
1,205,101
-266,486
CTMX icon
23
CytomX Therapeutics
CTMX
$528M
$6.99M 1.07%
3,081,414
+3,034,378
TSHA icon
24
Taysha Gene Therapies
TSHA
$1.29B
$6.95M 1.07%
3,009,870
+1,943,561
SAGE
25
DELISTED
Sage Therapeutics
SAGE
$6.58M 1.01%
721,599
-20,896